News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

John Bentil

Advertisement

Articles by John Bentil

How Tax Reform Will Affect the Pharmaceutical Industry

ByJohn Bentil
February 15th 2018

This article examines the key ways the new tax bill will impact the pharmaceutical industry.

Advertisement

Latest Updated Articles

  • How Tax Reform Will Affect the Pharmaceutical Industry
    How Tax Reform Will Affect the Pharmaceutical Industry

    Published: February 15th 2018 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up

2

Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments

3

Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial

4

Novo Nordisk Stock Reacts to Recent Board Changes

5

Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us